HOME >> BIOLOGY >> NEWS
Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

these actions of galanin are specific to cholinergic and not GABAergic.

Conclusion
On the basis of galanin-induced inhibition of ACh release, it has been hypothesized that the increased galanin innervation of cholinergic neurons might play an important role in worsening cognitive function of Alzheimer's disease patients.

An Alternate Theory
The research findings from this Canadian study suggest another alternative to that theory. Galanin overexpression in Alzheimer's disease may serve a compensatory role by enhancing the release of ACh from the remaining cholinergic basal forebrain neurons. This notion is supported by the observation that nerve growth factor, which rescues degenerating cholinergic neurons and increases ACh turnover by upregulating ChAT synthesis also induces galanin gene expression in the cholinergic basal forebrain . This recommends that an increase in galanin, through its excitatory effects on the cholinergic basal forebrain neurons, could cause increased release of ACh, which would be entirely consistent with the effects of nerve growth factor on cholinergic function.

An important consequence of the findings presented here relates to the development of galanin antagonists, which have been promoted as a possible treatment option for AD. Our findings should inject a note of caution in viewing such antagonists as "neuroprotective," a notion that is based on their potential to reverse the inhibitory effects of galanin, which may be receptor and region specific in the central nervous system.

Source
February edition of the Journal of Neurophysiology

The American Physiological Society (APS) was founded in 1887 to foster basic and applied science, much of it relating to human health. The Bethesda, MD-based Society has more than 10,000 members and publishes 3,800 articles in its 14 peer-reviewed journals every year.


'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
14-Mar-2002


Page: 1 2 3

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is ... has more than 20-years of telecommunications experience and over ten years in executive leadership. ... was acquired by CallTower in early 2018. , In this new role, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, ... that recognizes women of excellence in the field of intellectual property, and named ... Dwyer Women in IP Award aims to encourage and support women in their ...
(Date:8/26/2018)... ... August 25, 2018 , ... ... impact of a biofield energy treated nutraceutical to reduce inflammation and autoimmune disorders ... function and blood, as well as inflammation. The following data was reported:, ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... August 28, 2018 , ... ... spinal implants, announced today the successful completion of a $5.5 million funding round ... Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment in ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and ... a safety study performed on an allogeneic (donor derived) stem cell product for ... (NAVRMA) conference in September. He is also the organizer of Breakout Session ...
(Date:8/26/2018)... LINDA, Calif. (PRWEB) , ... August 23, 2018 ... ... virtual events for tech innovators, engineers, and scientists from around the world, will ... Immunology 2018 will cover an array of industries and disciplines, encompassing various research ...
(Date:8/23/2018)... STATION, N.J. (PRWEB) , ... August 23, 2018 , ... ... University by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers ... years later. , Visikol’s path from an idea to a successful biotech company ...
Breaking Biology Technology:
Cached News: